» Articles » PMID: 28771676

Allogeneic Haematopoietic Cell Transplantation for Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: a CIBMTR Analysis

Citing Articles

Challenges in overcoming advanced-stage or relapsed refractory extranodal NK/T-cell lymphoma: meta-analysis of individual patient data.

Kim T, Kim T, Han E, Min G, Jeon Y, Cho S Front Oncol. 2024; 14:1362367.

PMID: 39144825 PMC: 11322147. DOI: 10.3389/fonc.2024.1362367.


Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas.

Stuver R, Epstein-Peterson Z, Horwitz S Haematologica. 2023; 108(12):3244-3260.

PMID: 38037801 PMC: 10690914. DOI: 10.3324/haematol.2023.282717.


A Rare Case of Aggressive Disseminated Nasal-Type Epstein-Barr Virus-Positive Extranodal Natural Killer/T-Cell Lymphoma with Bone Marrow Involvement.

Yee A, Karim F, Giashuddin S, Grutman G Am J Case Rep. 2023; 24:e939286.

PMID: 37384825 PMC: 10286649. DOI: 10.12659/AJCR.939286.


Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis.

Berning P, Schmitz N, Ngoya M, Finel H, Boumendil A, Wang F Leukemia. 2023; 37(7):1511-1520.

PMID: 37157017 PMC: 10166457. DOI: 10.1038/s41375-023-01924-x.


EBV and Lymphomagenesis.

Sausen D, Basith A, Muqeemuddin S Cancers (Basel). 2023; 15(7).

PMID: 37046794 PMC: 10093459. DOI: 10.3390/cancers15072133.


References
1.
Tse E, Kwong Y . How I treat NK/T-cell lymphomas. Blood. 2013; 121(25):4997-5005. DOI: 10.1182/blood-2013-01-453233. View

2.
Murashige N, Kami M, Kishi Y, Kim S, Takeuchi M, Matsue K . Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms. Br J Haematol. 2005; 130(4):561-7. DOI: 10.1111/j.1365-2141.2005.05651.x. View

3.
Hari P, Raj R, Olteanu H . Targeting CD38 in Refractory Extranodal Natural Killer Cell-T-Cell Lymphoma. N Engl J Med. 2016; 375(15):1501-1502. DOI: 10.1056/NEJMc1605684. View

4.
Kim S, Choi J, Hyun S, Ki C, Oh D, Ahn Y . Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis. Lancet Haematol. 2015; 2(2):e66-74. DOI: 10.1016/S2352-3026(15)00002-2. View

5.
Koo G, Tan S, Tang T, Poon S, Allen G, Tan L . Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma. Cancer Discov. 2012; 2(7):591-7. DOI: 10.1158/2159-8290.CD-12-0028. View